All In Biotech

Drug Trial Radar · NCT03678025

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer

Last checked: Nov 19, 2026Latest source record: Oct 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 1,273 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

1,273

Planned (sponsor's estimate)

Start

Sep 24, 2018

Primary completion

Apr 1, 2033

Study completion Oct 1, 2036

Sponsor

Lead sponsor
SWOG Cancer Research NetworkResearch network
Sponsor type
Research network
Collaborators
National Cancer Institute (NCI)
First posted
Sep 19, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Male only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.

Conditions

  • Castration Levels of Testosterone
  • Metastatic Prostatic Adenocarcinoma
  • Stage IV Prostate Cancer AJCC v8
  • Stage IVA Prostate Cancer AJCC v8
  • Stage IVB Prostate Cancer AJCC v8

Interventions

  • AbirateroneDrug

    Given PO

  • BicalutamideDrug

    Given PO

  • DegarelixDrug

    Given via injection

  • DocetaxelDrug

    intravenous

  • FlutamideDrug

    Given PO

  • Goserelin AcetateDrug

    Given SC

  • Histrelin AcetateDrug

    Receive SC

  • Leuprolide AcetateDrug

    Receive SC or IM

  • NilutamideDrug

    Given PO

  • OrchiectomyProcedure

    Undergo bilateral orchiectomy

  • PrednisoneDrug

    Given PO

  • Quality-of-Life AssessmentOther

    Ancillary studies

  • Radiation TherapyRadiation

    Standard radiation

  • Radical ProstatectomyProcedure

    Standard surgery

  • TriptorelinDrug

    injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall survival (OS)Time frame: From date of randomization to date of death due to any cause, assessed up to 8 years

Locations

338 sites in 5 countries. Site status is shown where the registry gives one.

  • Banner MD Anderson Cancer Center

    Gilbert, Arizona · Recruiting

  • Cancer Center at Saint Joseph's

    Phoenix, Arizona · Recruiting

  • Mayo Clinic Hospital in Arizona

    Phoenix, Arizona · Suspended

  • Mayo Clinic in Arizona

    Scottsdale, Arizona · Suspended

  • University of Arizona Cancer Center-Orange Grove Campus

    Tucson, Arizona · Recruiting

  • University of Arizona Cancer Center-North Campus

    Tucson, Arizona · Recruiting

  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas · Recruiting

  • Kaiser Permanente-Deer Valley Medical Center

    Antioch, California · Recruiting

  • Community Cancer Institute

    Clovis, California · Recruiting

  • University Oncology Associates

    Clovis, California · Suspended

  • City of Hope Comprehensive Cancer Center

    Duarte, California · Recruiting

  • Kaiser Permanente Dublin

    Dublin, California · Recruiting

  • Kaiser Permanente-Fremont

    Fremont, California · Recruiting

  • Fresno Cancer Center

    Fresno, California · Recruiting

  • Kaiser Permanente-Fresno

    Fresno, California · Recruiting

  • UC San Diego Moores Cancer Center

    La Jolla, California · Recruiting

  • Tibor Rubin VA Medical Center

    Long Beach, California · Recruiting

  • Los Angeles County-USC Medical Center

    Los Angeles, California · Recruiting

  • USC / Norris Comprehensive Cancer Center

    Los Angeles, California · Recruiting

  • Fremont - Rideout Cancer Center

    Marysville, California · Recruiting

  • Kaiser Permanente-Modesto

    Modesto, California · Recruiting

  • Kaiser Permanente Oakland-Broadway

    Oakland, California · Recruiting

  • Kaiser Permanente-Oakland

    Oakland, California · Recruiting

  • Desert Regional Medical Center

    Palm Springs, California · Recruiting

  • Stanford Cancer Institute Palo Alto

    Palo Alto, California · Recruiting

  • Kaiser Permanente-Rancho Cordova Cancer Center

    Rancho Cordova, California · Recruiting

  • Kaiser Permanente-Redwood City

    Redwood City, California · Recruiting

  • Kaiser Permanente-Richmond

    Richmond, California · Recruiting

  • Rohnert Park Cancer Center

    Rohnert Park, California · Recruiting

  • Kaiser Permanente-Roseville

    Roseville, California · Recruiting

  • The Permanente Medical Group-Roseville Radiation Oncology

    Roseville, California · Recruiting

  • Kaiser Permanente Downtown Commons

    Sacramento, California · Recruiting

  • Mercy Cancer Center - Sacramento

    Sacramento, California · Recruiting

  • University of California Davis Comprehensive Cancer Center

    Sacramento, California · Recruiting

  • Kaiser Permanente-South Sacramento

    Sacramento, California · Recruiting

  • South Sacramento Cancer Center

    Sacramento, California · Recruiting

  • Kaiser Permanente-San Francisco

    San Francisco, California · Recruiting

  • Kaiser Permanente-Santa Teresa-San Jose

    San Jose, California · Recruiting

  • Kaiser Permanente San Leandro

    San Leandro, California · Recruiting

  • Pacific Central Coast Health Center-San Luis Obispo

    San Luis Obispo, California · Recruiting

Showing 40 of 338 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.